Inducible nitric oxide synthase (iNOS) expression is regulated at both the transcriptional and post-transcriptional level in epithelial cells. The aim of this study was to characterize the effects of tyrosine phosphorylation on iNOS activity. In a human intestinal epithelial cell line stimulated with cytokines, tyrosine phosphorylation of human iNOS protein was observed after 30 min exposure to pervanadate (PV), an inhibitor of protein tyrosine phosphatases. 4-Amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo [3,4-d]pyrimidine, a specific inhibitor of Src tyrosine kinases, abolished the PVinduced iNOS tyrosine phosphorylation. Cotransfection of Src with iNOS cDNA in human embryonic kidney (HEK) 293 cells resulted in a threefold (Po0.001) increase of iNOS protein levels and tyrosine phosphorylation of iNOS. In the presence of Src, 76% of wild-type (wt) iNOS was redistributed to detergent-insoluble domains and iNOS activity was decreased by 28% (Po0.05) despite increased iNOS protein levels. Analysis of iNOS tyrosine mutants revealed decreased Src-induced effects in Y151F iNOS mutant. Using a GST-fusion protein containing a domain encompassing Y151, we show that Y151 is a direct substrate for active Src in vitro. These findings indicate a role for iNOS tyrosine phosphorylation in the regulation of iNOS activity and the implication of Src tyrosine kinases in this pathway.
Introduction
The inducible nitric oxide synthase (iNOS) protein is responsible for sustained release of nitric oxide (NO) and is typically synthesized in response to proinflammatory stimuli (MacMicking et al., 1997) .
iNOS protein is induced in a large variety of human diseases, including intestinal disorders such as chronic inflammatory bowel diseases and colon adenocarcinoma (Singer et al., 1996; Ambs et al., 1998; Kroncke et al., 1998) . Enhanced iNOS protein expression, which has been detected in the inflammatory infiltrate and epithelial cells of the injured intestinal mucosa (Singer et al., 1996; Ambs et al., 1998) , is associated with increased iNOS activity and generation of NO-derived products (Rachmilewitz et al., 1995; Kimura et al., 1997; Ambs et al., 1998) . However, the pathological function of NO still remains largely uncertain in view of its multiple and even opposite effects. In fact, besides the amount of NO produced, the NO-mediated actions have been recently suggested to depend on many other factors such as the nature of iNOS induction signal (Espey et al., 2000) , subsequent interactions of iNOS with other cell components (Miller and Sandoval, 1999) and the redox environment (Andre and Felley-Bosco, 2003) . Therefore, understanding the post-translational regulation of iNOS is essential to clarify the role of this enzyme in the pathogenesis of intestinal disorders.
In addition to the multiple and species-specific mechanisms regulating iNOS protein expression (Kroncke et al., 1998) , a few studies have described a possible regulation of enzyme activity by post-translational processing of the protein including active dimer formation and localization (Albakri and Stuehr, 1996; Rumbo et al., 2005) , palmitoylation (NavarroLerida et al., 2004) and protein degradation (FelleyBosco et al., 2000; Musial and Eissa, 2001 ). Finally, iNOS protein has also been shown to undergo phosphorylation in stimulated murine macrophages (Vodovotz et al., 1995; Pan et al., 1996; Salh et al., 1998) . In the latter, abolition of iNOS phosphorylation is associated with reduced NO production (Salh et al., 1998) . Pan et al. (1996) have shown that enhancement of iNOS phosphorylation using a protein tyrosine phosphatase inhibitor is associated with increased iNOS activity. However, data presented in their study did not allow to conclude that tyrosine phosphorylation has a direct effect on iNOS function and the participating kinases were not identified either. Our study was aimed at determining whether tyrosine phosphorylation regulates iNOS in human cells and characterizing which are the mechanisms involved in this process.
Results
Pervanadate (PV) exposure reveals iNOS tyrosine phosphorylation in intestinal epithelial cells Enhancement of iNOS phosphorylation using a protein tyrosine phosphatase inhibitor is associated with increased iNOS activity in murine macrophages (Pan et al., 1996) . To investigate whether the same regulation is present in human cells and to further characterize it, intestinal human DLD-1 cells stimulated with cytokines for 14 h to induce iNOS were treated with PV, an inhibitor of protein tyrosine phosphatases (Huyer et al., 1997) . Exposure to PV induced a time-and dosedependent increase in total protein tyrosine phosphorylation, the maximal effect being obtained within 30 min and with 250 mM PV (Supplementary data). In order to assess the effect of PV on iNOS tyrosine phosphorylation, cytokine-stimulated cells were treated or not with 250 mM PV for 30 min, after which anti-phosphotyrosine Western blot analysis was carried out on anti-iNOSimmunoprecipitated fraction (Figure 1a ). Although no band was observed in control cytokine-stimulated cells, a significant 130 kDa band was detected in PV-treated cytokine-stimulated cells. Reprobing blots with antiiNOS antibody indicated that the 130 kDa protein detected using anti-phosphotyrosine antibody corresponded to iNOS protein and that the amount of immunoprecipitated iNOS from control and PV-treated cells was similar (Figure 1a) .
The PV-induced iNOS phosphorylation on tyrosine residues was confirmed by phosphoamino-acid analysis (Figure 1b) , which also showed iNOS phosphorylation on serine residues in control and PV-treated cells. In contrast to observations in murine macrophages (Pan et al., 1996) , no significant change was observed in iNOS activity measured by citrulline production (6878 pmol/ min/mg protein in control vs 7079 pmol/min/mg protein in PV-treated cells, n ¼ 5).
To examine the subcellular distribution of the tyrosine-phosphorylated iNOS, lysates from PV-treated cells were centrifuged at 100 000 g, and after collection of cytosols, pellets were extracted as described under experimental procedures. Analysis of tyrosine phosphorylation on immunoprecipitated iNOS from either fractions revealed that 85% of the total tyrosine phosphorylated iNOS is found in the particulate fraction ( Figure 1c ).
Involvement of Src tyrosine kinases in the PV-induced iNOS tyrosine phosphorylation
In order to further investigate PV-induced tyrosine phosphorylation, the potential signaling pathway was sought. Analysis of iNOS amino-acid sequence reveals a number of phosphorylation consensus sites for tyrosine kinases of the Src family. The latter have been recently associated with different signal transduction pathways in intestinal cells (Keely et al., 2000; Chiu et al., 2002) . Preincubation (30 min) of DLD-1 cells with 25 mM 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo [3,4-d] pyrimidine (PP2), a specific inhibitor of Src tyrosine kinases (Hanke et al., 1996) , markedly reduced the total protein tyrosine phosphorylation observed in the presence of PV (Figure 2a ). At this dose, PP2 was more efficient than 300 mM of either erbstatin or genistein, other tyrosine kinase inhibitors (data not shown). Similarly, PP2 reduced in a dose-dependent manner the PV-dependent iNOS tyrosine phosphorylation (Figure 2b) , with a nearly complete inhibition being observed at 25 mM PP2. This finding indicates the implication of Src tyrosine kinases in the phosphorylation of iNOS.
To further investigate iNOS tyrosine phosphorylation, PV effects were analysed in human embryonic kidney (HEK) 293 cells transfected with wild-type (wt) iNOS cDNA and exposed to 100 mM PV for 30 min. PV exposure increased total protein (Figure 3a , left panel) and human iNOS (Figure 3a , right panel) tyrosine phosphorylation. A basal human iNOS tyrosine phosphorylation was detected in transfected HEK 293 cells, in contrast to cytokine-induced human iNOS in DLD-1 cells. As PV is insulinomimetic (Posner et al., 1994) and c-Src is known to mediate insulin signaling, insulin was used as physiological tyrosine kinase activator. Insulin . This effect may be explained by the fact that iNOS activity, measured by the arginine conversion assay, decreased by 28% (Po0.05, n ¼ 3, Figure 4c , right panel) in the presence of active Src and was accompanied by accumulation of iNOS mainly in the detergent-insoluble pellet ( Figure 4d ). Similar effects were observed with Fyn coexpression where a 20-fold increase in iNOS expression (Po0.05, n ¼ 4), but no significant change in nitrite accumulation in the conditioned medium were observed. Altogether, these data suggest that Src-family activitydependent phosphorylation leads to redistribution and partial inactivation of iNOS.
To buttress the involvement of tyrosine phosphorylation in Src-dependent regulation of iNOS, Tyr to Phe iNOS mutants were constructed. Target tyrosines were selected based on conservation and consensus motifs for Total homogenate (left panel) or iNOS immunoprecipitate (right panel) were analysed by Western blot using anti-phosphotyrosine antibodies (pTYR). iNOS immunoprecipitates were also analysed using anti-iNOS antibodies (iNOS).
Tyrosine phosphorylation of human iNOS P Hausel et al preferential phosphorylation by Src and receptor tyrosine kinase identified in vitro by screening peptide libraries (Songyang and Cantley, 1995) . The predicted motif based on such studies include (1) acidic residues favored but not necessary in the À4, À3 and À2 position upstream of the phosphorylation site, (2) isoleucine or valine in the À1 position, (3) a small or acidic amino acid in the þ 1 position and (4) a large hydrophobic amino acid in the þ 3 position. The N-and C-terminus region of iNOS contain three, respectively, two, conserved tyrosines with at least two of the four parameters described above that were mutated in NtermY/F and CtermY/F (Y151F/Y299F/Y336F and Y1025F/ Y1055F, Figure 5a ). The Tyr to Phe substitutions in the N-terminus, but not in the C-terminus, decreased Src-induced phosphorylation of iNOS (Figure 5b ). In parallel, the Src-induced accumulation of iNOS in the detergent-insoluble pellet decreased by 40% in the NtermY/F mutant (Po0.05, n ¼ 3, Figure 5c ). This further supports the involvement of iNOS phosphorylation mediated by Src in subcellular redistribution. Screening of single mutants revealed that the Y151F mutation, although presenting a basal tyrosine phosphorylation, had a 90% lower Src-induced phosphorylation (Po0.01, n ¼ 3, Figure 6a ) and blunted the accumulation of iNOS in the detergent-insoluble pellet (data not shown). Furthermore, the mutation led to a 28% increase in nitrite accumulation as compared to wt protein (Po0.01, n ¼ 13, Figure 6b ). To test whether iNOS is a direct substrate for active Src, we generated GST-fusion proteins containing amino acids 100-201 of either wt or Y151F iNOS (Figure 7a ). These fusion proteins were purified and incubated in the presence of active Src, Mn 2 þ , Mg 2 þ and radiolabeled ATP. The reaction products were resolved by SDSÀPAGE and analysed by autoradiography (Figure 7b , upper panel) and anti-GST immunoblotting (Figure 7b, lower panel) . A band corresponding to the GST-iNOS-fusion protein was phosphorylated by active Src when wt iNOS but not Y151F mutant was present. These data show that tyrosine 151 of iNOS can be phosphorylated directly by the active Src protein tyrosine kinase, in vitro.
Altogether, these data indicate that tyrosine 151 is a target of Src-induced tyrosine phosphorylation, which leads to the accumulation of iNOS in detergentinsoluble fraction and is accompanied by decreased iNOS activity.
Discussion
Negative regulation of iNOS at transcriptional (Taylor et al., 1998; Feng et al., 2002) , translational (Lee et al., 2003) and post-translational level (Albakri and Stuehr, 1996; Ratovitski et al., 1999a, b; Felley-Bosco et al., 2000; Musial and Eissa, 2001; Kolodziejski et al., 2002) constitute a well-orchestrated control of an enzyme participating in inflammatory response. Here, we show that regulation of iNOS activity and subcellular distribution involves tyrosine phosphorylation of the protein. Indeed, phosphorylation on tyrosine residues was observed in iNOS expressed in human intestinal epithelial cells upon cytokine stimulation in the presence of PV. The Src-family-selective tyrosine kinase inhibitor PP2 prevented PV-induced tyrosine phosphorylation of iNOS. This is in agreement with our finding that most of tyrosine phosphorylated iNOS was in the particulate fraction where Src tyrosine kinases are abundant (Latour and Veillette, 2001 ). Furthermore, several Tyr residues, predicted to be phosphorylated by NetPhos analysis (www.cbs.dtu.dk/services/NetPhos), are located in consensus motifs of c-Src tyrosine kinase (Songyang and Cantley, 1995) . PV increased tyrosine phosphorylation of iNOS also in transfected HEK 293 cells. Since PV is a strong insulinomimetic (Posner et al., 1994) , we investigated whether insulin was able to induce iNOS tyrosine phosphorylation. Increased total protein tyrosine phosphorylation, which was used as a positive Active Src or Fyn coexpression led to a dramatic increase in wt iNOS tyrosine phosphorylation. Transfection of iNOS containing putative Src-targeted tyrosines mutated to phenylalanine revealed that mutations in the N-term but not in C-term significantly reduced Srcinduced iNOS phosphorylation. Out of the three tyrosines mutated in the N-terminus, Y151 was identified in cells and in vitro as the tyrosine responsible for Src-induced phosphorylation. Since a residual Srcinduced phosphorylation is detected in Y151F mutant, tyrosines other than Y151 are phosphorylated and further work is necessary to identify alternative targets.
Y151 contains two of the four parameters described for optimal Src substrate sequences (Songyang and Cantley, 1995) , but this has been also described for other Src substrate (Mariner et al., 2001 ). Y151 is conserved among different species and occurs within a helix-loophelix domain of iNOS (Figure 8 ). This suggests that a helix-loop-helix domain is available for modification by phosphorylation and perhaps for interaction with other proteins. Indeed, the two-helix bundle makes limited interactions with the remainder of the structure, it is not directly involved in substrate or cofactors binding and it is not located in the dimerization surface (Fischman et al., 1999) . Therefore, it is possible that phosphorylation of Y151 is a signal necessary for recruitment of other proteins. This perspective opens different avenues of investigation considering that SH2, PTB and, more recently, C2 domain-containing proteins have been described to bind phosphotyrosine (Sondermann and Kuriyan, 2005) .
Constitutively active Src coexpression led to wt iNOS accumulation in detergent-insoluble fractions, while Y151F mutant accumulated in such fraction to a lower degree. This suggests that tyrosine phosphorylation is implicated in subcellular redistribution. Post-translational modification of iNOS has already been associated with iNOS targeting since palmitoylation is necessary for active iNOS sorting (Navarro- Lerida et al., 2004) . In the presence of active Src, most of phosphorylated iNOS accumulated in a detergent-insoluble fraction and correlated with a loss in iNOS activity. Since Src coexpression resulted in a threefold increase in iNOS protein levels, this may indicate that either iNOS overexpression is the limiting factor or that translocation to detergent-insoluble fraction is associated to a decrease of iNOS activity. The second hypothesis is favored by the fact that Src coexpression with iNOS Y151F mutant led to increased nitrite accumulation as compared to wt. As iNOS protein is active in a dimeric form (Baek et al., 1993) , decreased activity could imply, for example, that phosphorylated monomers accumulate in the detergent-insoluble pellet. Unfortunately, this hypothesis is not easy to address since solubilization of iNOS was obtained only in the presence of 2% SDS, which is known to alter by itself iNOS activity (Vodovotz et al., 1995) .
In stimulated murine macrophages treated with vanadate, increase in iNOS activity has been observed (Pan et al., 1996) . In this study, it was not possible to conclude that tyrosine phosphorylation had a direct effect on iNOS function. Therefore, since we did not observe an increase in iNOS activity neither after PV treatment of cytokine-stimulated intestinal epithelial cells nor after Src coexpression in HEK 293 cells, it is possible that in murine macrophages tyrosine phosphorylation regulates differently iNOS activity.
Stimulation of cells during 30 min with insulin resulted in a more modest level of phosphorylation compared to coexpression of active Src. Accordingly, neither increased levels of iNOS nor a significant redistribution to insoluble fraction was observed after insulin exposure. Nevertheless, Src-induced iNOS accumulation in insoluble fraction may be relevant in pathologies such as cancer where overexpression of the c-Src protein and an increase in its specific activity have been observed (Irby and Yeatman, 2000) . Concerning (Sayle and Milner-White, 1995) using file nos4 from Protein Data Bank (Fischman et al., 1999) . Tyrosine 151 in helix-loop-helix is highlighted in blue. (b) Sequence alignment of iNOS showing conservation of Y151 in different species (P35228, human; Q97604, dog; Q6P6AO, mouse, Q06518, rat; Q9BDH6, horse; 054705, guinea pig; Q97703, chicken). this point, it is worth noting that increased levels of iNOS expression and/or activity have been observed in human breast (Thomsen et al., 1995) , central nervous system (Cobbs et al., 1995) and colon tumors (Ambs et al., 1998) . Since both Src and iNOS expression vary depending on tumor stage in colon cancer, it would be interesting to determine in more detail their relationship to tumor evolution.
Materials and methods

Cell culture and treatment
Human intestinal epithelial DLD-1 and HEK 293 cells were cultured as described previously (Felley-Bosco et al., 2000; Andre et al., 2005) . In some experiments, DLD-1 cells stimulated for 14 h by cytokines (Felley-Bosco et al., 2000) were exposed to PV prepared according to Huyer et al. (1997) . When present, PP2 (Calbiochem, La Jolla, CA, USA) was added 30 min before PV. Starvation was performed by incubation of the cells 12-14 h in medium containing 0.5% FBS before stimulation with 100 nM insulin or addition of PV.
Plasmid construction and transfection HEK 293 cells were transfected with either human iNOS wt (Andre et al., 2005) or tyrosine mutants (see below) using DMRIE-C (Invitrogen) according to the manufacturer's instructions. Cells were used 72 h after the beginning of the transfection.
To generate tyrosine mutants (Y151F, Y299F, Y336F, Y1025F and Y1055F), each tyrosine residue was mutated to phenylalanine by overlapping polymerase chain reaction. The Y-Nterm-F and Y-Cterm-F tyrosine mutants were constructed by recombination of the single tyrosine mutant constructs. In some experiments, cells were transfected with pMT2 (kind gift of Dr W Moolenaar, NKI, The Netherlands; Abram and Courtneidge, 2000) encoding either a constitutively active cSrc, in which the inhibitory intramolecular interaction between phosphotyrosine 527 and the SH2 domain is disrupted (Y527A mutation), or a kinase-dead Src (K295M mutation). Constitutively active Fyn (Y528F, Paccani et al. (2005) , kind gift of Dr C Baldari, University of Siena, Italy) was also tested.
Cell lysate preparation
Cell monolayers were washed three times with ice-cold PBS and then scraped in lysis buffer containing 50 mM HEPES (pH 7.4), 1 mM EGTA, 10% glycerol, 2 mM tetrahydrobiopterin, 2 mM FAD, 5 mg/ml pepstatin, 3 mg/ml aprotinin, 10 mg/ml leupeptin, 0.1 mM 4-(2-aminoethyl)-benzenesulfonyl fluoride, 1 mM sodium vanadate and 50 mM sodium fluoride. Samples were then homogenized by three freeze-thaw cycles. In some experiments, cell homogenates were centrifuged at 100 000 g for 15 min at 41C (Beckman Optima TLX Ultracentrifuge) to separate the soluble from the particulate fraction.
iNOS activity Calcium-independent NOS activity was assessed as described previously (Felley-Bosco et al., 1994) . The activity of iNOS was also assessed indirectly by measuring nitrite accumulation in conditioned medium (Vecchini et al., 1997) .
iNOS immunoprecipitation
Unless otherwise stated, immunoprecipitations were carried out on cell lysates incubated during 1 h at 41C after addition of 125 mM NaCl, 1% Triton X-100, 1% Nonidet P-40, 0.5% SDS, 5 mM N-ethylmaleimide and 10 mM lactacystin. Samples were then centrifuged at 100 000 g for 15 min to separate detergent-insoluble material. The resulting supernatants were precleared by a 1-h incubation with protein A-Sepharose beads (Amersham Pharmacia Biotech, Dubendorf, Switzerland) before overnight incubation with a rabbit polyclonal anti-human iNOS antibody (NO53) (Singer et al., 1996) at a dilution of 1:500. Protein A-Sepharose beads were then added for a further 2 h incubation. Bound immune complexes were pelleted, washed four times in lysis buffer and eluted by incubation at 951C for 10 min with twofold concentrated Laemmli buffer. In active Src cotransfection experiments, iNOS Western blots were also performed on 100 000 g pellets after solubilization in 2% SDS.
Western blot analysis
Western blots to detect iNOS protein were carried out as previously described using NO53 antibody (Felley-Bosco et al., 2000; Andre et al., 2005; Rumbo et al., 2005) . To determine tyrosine phosphorylation membranes were incubated overnight with 2% gelatin (Sigma, Buchs, Switzerland) in PBS-T (PBS (pH 7.4), 0.1% Tween-20), blots were incubated with mouse monoclonal anti-phosphotyrosine antibodies (1:2500) (PY20, Transduction Laboratories, San Diego, CA, USA). Blots were then probed with horseradish peroxidase-conjugated secondary antibodies (1:10 000) and the immunoreactive proteins were visualized by enhanced chemiluminescence (Amersham Pharmacia Biotech, Dubendorf, Switzerland). Quantification of the bands was by densitometry using ImageQuant software (Amersham Bioscience, Uppsala, Sweden). Densitometry was performed on nonsaturated films.
Phosphate labeling and phosphoamino-acid analysis Cells were washed and incubated in phosphate-free RPMI 1640 medium supplemented with insulin, transferrin, EGF, hydroxycortisone and selenium for 2 h. Then, medium was changed and 0.2 mCi/ml of [ 32 P]orthophosphate were added. After 90 min, cells were treated with 250 mM PV during 30 min. Then, iNOS immunoprecipitation was performed as above. Immunocomplexes were analysed on 7.5% SDS-PAGE. Gels were then dried and exposed to Kodak X-AR films at À701C. The band of the gel containing the phosphorylated iNOS was cut and rehydrated in 50 mM NH 4 HCO 3 , 0.1% SDS, and 1% b-mercaptoethanol, boiled for 5 min and shaken for 2 h at room temperature. After centrifugation for 10 min, the pellet was re-extracted as above, and the supernatants (1 ml) were combined. After the addition of 1 ml of RNAse A solution (10 mg/ml), proteins were precipitated by the addition of TCA (15% final) at 41C for 90 min. Proteins were pelleted, washed in 1 ml of 10% TCA and then in 1 ml ethanol before hydrolyzation in 50 ml of 6 N HCl for 70 min at 1101C. After lyophilization, samples were dissolved in 5 ml of glacial acetic acid and formic acid containing a mixture of 250 mg/ml phosphoserine, phosphothreonine and phosphotyrosine. Phosphoamino-acid analysis was performed by thin-layer chromatography using a HTLE 7000 electrophoresis system (CBS Scientific Company, Del Mar, CA, USA) according to the manufacturer's protocol. Position of the marker phosphoamino acids was detected by the ninhydrin reaction, and the dry plates were exposed at À701C for autoradiography.
Purification of recombinant proteins iNOS fragments (amino acid 100-201) from wt or Y151F were subcloned into pGEX4T and expressed in bacteria (BL21) by incubation for 4 h at 371C in the presence of isopropyl-1-thio-D-galactopyranoside (IPTG, 0.5 mM). Recombinant proteins were purified using glutathione-Sepharose (Amersham Pharmacia Biotech). Bacterial extracts containing GST-fusion proteins were prepared by centrifugation of bacterial cultures, lysis of pelleted bacteria in 50 mM Tris (pH 7.4), 100 mM NaCl, 5 mM EDTA, 1% (w/v) Triton X-100, 3 mg/ml aprotinine, 10 mg/ml leupeptin, 5 mg/ml pepstatin, 100 mM AEBSF; sonication; and centrifugation at 18 000 r.p.m. (Sorvall) for 30 min at 41C. The supernatant was incubated with glutathioneSepharose beads (Amersham) overnight. The resin was washed with 10 bed volumes of lysis buffer and stored at 41C. GSTfusion proteins were eluted from the resin with 20 mM reduced glutathione for 45 min at RT and dialysed in Tris 20 mM, 100 mM NaCl (pH 7.4).
Src was subcloned into pET30 (Novagen) and expressed in BL21 after overnight induction with IPTG at 161C. N-terminal His-tagged Src was purified with Ni-NTA agarose beads (Qiagen) as suggested by the manufacturer, except that buffers contained also 1 mM EGTA and 1 mM EDTA. Dialysis was performed in the same buffer as for GST-fusion constructs, except that 10% glycerol was added.
The purity of the recombinant proteins was confirmed by SDS-PAGE and Coomassie Blue gel staining.
In vitro Src kinase assay GST-iNOS-fusion proteins (4.5 mg) were phosphorylated in vitro by Src (90 ng) containing 25 mM Tris-Cl (pH 7.2), 30 mM MgCl 2 , 21 mM MnCl 2 , 1.5 mM EGTA, 0.5 mM dithiothreitol, unlabeled ATP at a final concentration of 0.1 mM and 2.5 ml of [g-32 P]ATP (2 mCi/ml, Hartmann). Reaction was carried out at 301C for 30 min. The reactions were stopped by addition of SDS-PAGE loading buffer and boiling for 5 min. The sample were separated by 10% SDS-PAGE, and transferred to PVDF membranes followed by autoradiography. To confirm the identity of the substrate, the membrane was then incubated with anti-GST antibodies and secondary antibodies as described above.
Data analysis
Results are expressed relative to homogenate or control values. Values are means7s.e.m. of n independent experiments and statistical analysis was performed using Student's t-test, unless stated otherwise.
